# Detailed Report - Step 1: Data Configuration and Understanding

## Executive Summary

This report presents the comprehensive analysis of Step 1, which focused on configuring the working environment and understanding the SIDERO-WT and ATLAS datasets for cefiderocol resistance prediction. The analysis successfully established the data infrastructure, normalized MIC values, defined binary resistance targets, and performed exploratory data analysis.

## Key Statistics

- **Total Isolates Analyzed**: 1,014,420
- **Cefiderocol Resistance**: 1.97% (940 isolates)
- **Datasets**: SIDERO-WT (47,615) + ATLAS (966,805)

## 1. Environment Configuration

### 1.1 Infrastructure Setup
- **Python Environment**: Configured with essential libraries for data analysis
- **Project Structure**: Organized directory structure with `outputs/plots/` for visualizations
- **Processing Pipeline**: Modular functions for data loading, cleaning, and analysis

### 1.2 Technical Implementation
- **Data Loading Functions**: Robust error handling for Excel file processing
- **MIC Value Cleaning**: Automated removal of non-numeric characters (≤, ≥, etc.)
- **Column Standardization**: Consistent naming conventions across datasets
- **Missing Value Management**: Proper handling of NaN values

## 2. Dataset Exploration

### 2.1 SIDERO-WT Dataset (1.xlsx)
**Dataset Characteristics:**
- **Size**: 47,615 isolates × 20 variables
- **Primary Focus**: Cefiderocol susceptibility testing
- **Geographic Coverage**: Multi-regional data collection
- **Temporal Range**: Year-based collection data

**Key Variables:**
| Variable | Description | Data Type |
|----------|-------------|-----------|
| `cefiderocol_mic` | Cefiderocol MIC values | Numeric |
| `meropenem_mic` | Meropenem MIC values | Numeric |
| `species` | Bacterial species identification | Categorical |
| `region` | Geographic region | Categorical |
| `year` | Collection year | Numeric |

### 2.2 ATLAS Dataset (2.xlsx)
**Dataset Characteristics:**
- **Size**: 966,805 isolates × 134 variables
- **Primary Focus**: Comprehensive antimicrobial susceptibility testing
- **Geographic Coverage**: Global coverage with country-level data
- **Temporal Range**: Year-based collection data

**Key Variables:**
| Variable | Description | Data Type |
|----------|-------------|-----------|
| `meropenem_mic` | Meropenem MIC values | Numeric |
| `species` | Bacterial species identification | Categorical |
| `country` | Country of origin | Categorical |
| `year` | Collection year | Numeric |

## 3. Data Normalization and Preprocessing

### 3.1 MIC Value Standardization
**Implemented Process:**
1. **Character Cleaning**: Removal of non-numeric characters (≤, ≥, <, >)
2. **Type Conversion**: Conversion to float format
3. **Missing Value Handling**: Standardized NaN representation
4. **Validation**: Quality checks for data integrity

**Example Transformation:**
- Input: "≤2", "≥8", "4"
- Output: 2.0, 8.0, 4.0

## 4. Binary Resistance Target Definition

### 4.1 Cefiderocol Resistance Criteria
**Definition**: MIC ≥ 4 µg/mL = Resistant
**Rationale**: Based on clinical breakpoints and regulatory guidelines

### 4.2 Resistance Distribution Results
| Category | Count | Percentage |
|----------|-------|------------|
| **Sensitive** | 46,675 | 98.03% |
| **Resistant** | 940 | 1.97% |
| **Total** | 47,615 | 100% |

**Key Observations:**
- **Low Resistance Prevalence**: Only 1.97% of isolates show cefiderocol resistance
- **Class Imbalance**: Significant imbalance between sensitive and resistant classes
- **Clinical Relevance**: Low resistance rates suggest good antimicrobial activity

## 5. Exploratory Data Analysis (EDA)

### 5.1 Species Distribution Analysis

#### SIDERO-WT Dataset - Top 10 Species
| Rank | Species | Count | Percentage |
|------|---------|-------|------------|
| 1 | Pseudomonas aeruginosa | 7,700 | 16.17% |
| 2 | Escherichia coli | 7,583 | 15.92% |
| 3 | Klebsiella pneumoniae | 7,285 | 15.30% |
| 4 | Acinetobacter baumannii | 4,384 | 9.21% |
| 5 | Serratia marcescens | 3,603 | 7.57% |
| 6 | Enterobacter cloacae | 2,615 | 5.49% |
| 7 | Klebsiella oxytoca | 2,155 | 4.53% |
| 8 | Stenotrophomonas maltophilia | 2,031 | 4.27% |
| 9 | Proteus mirabilis | 1,373 | 2.88% |
| 10 | Klebsiella aerogenes | 1,328 | 2.79% |

#### ATLAS Dataset - Top 10 Species
| Rank | Species | Count | Percentage |
|------|---------|-------|------------|
| 1 | Staphylococcus aureus | 166,579 | 17.22% |
| 2 | Escherichia coli | 119,898 | 12.40% |
| 3 | Pseudomonas aeruginosa | 110,448 | 11.42% |
| 4 | Klebsiella pneumoniae | 101,194 | 10.46% |
| 5 | Streptococcus pneumoniae | 48,017 | 4.97% |
| 6 | Enterobacter cloacae | 46,254 | 4.78% |
| 7 | Acinetobacter baumannii | 43,369 | 4.48% |
| 8 | Enterococcus faecalis | 38,064 | 3.94% |
| 9 | Haemophilus influenzae | 32,664 | 3.38% |
| 10 | Streptococcus agalactiae | 26,517 | 2.74% |

### 5.2 Cross-Dataset Species Comparison
**Common Species Analysis:**
- **Pseudomonas aeruginosa**: Present in both datasets (7,700 vs 110,448)
- **Escherichia coli**: High representation in both (7,583 vs 119,898)
- **Klebsiella pneumoniae**: Consistent presence (7,285 vs 101,194)
- **Acinetobacter baumannii**: Similar proportions (4,384 vs 43,369)

## 6. Visualization Outputs

### 6.1 Generated Plots

#### Cefiderocol MIC Distribution
![Cefiderocol MIC Distribution](outputs/plots/cefiderocol_mic_distribution.png)

*This plot shows the distribution of cefiderocol MIC values in the SIDERO-WT dataset. The majority of isolates show low MIC values, indicating good susceptibility to cefiderocol.*

#### Temporal Evolution of Cefiderocol MIC
![Cefiderocol MIC by Year](outputs/plots/cefiderocol_mic_by_year.png)

*This box plot shows the evolution of cefiderocol MIC values over time. It allows identification of temporal trends in susceptibility patterns.*

#### Cefiderocol Resistance by Region
![Resistance by Region](outputs/plots/cefiderocol_resistance_by_region.png)

*This plot presents the geographic distribution of cefiderocol resistance patterns. It reveals regional variations in resistance prevalence.*

#### Meropenem MIC Distribution (ATLAS)
![Meropenem MIC Distribution](outputs/plots/meropenem_mic_distribution_atlas.png)

*This plot shows the distribution of meropenem MIC values in the ATLAS dataset, allowing comparison with cefiderocol patterns.*

## 7. Key Findings and Insights

### 7.1 Resistance Patterns
1. **Low Cefiderocol Resistance**: Only 1.97% resistance rate suggests excellent antimicrobial activity
2. **Class Imbalance**: Significant imbalance requires special consideration in modeling
3. **Geographic Variation**: Regional differences observed in resistance patterns

### 7.2 Species Distribution
1. **Gram-Negative Dominance**: SIDERO-WT focuses on Gram-negative pathogens
2. **Broad Coverage**: ATLAS includes both Gram-positive and Gram-negative species
3. **Clinical Relevance**: Major pathogens well-represented in both datasets

### 7.3 Data Quality
1. **High Completeness**: Minimal missing data in key variables
2. **Consistent Formatting**: Well-standardized data structure
3. **Temporal Coverage**: Sufficient historical data for trend analysis

## 8. Recommendations for Next Steps

### 8.1 Modeling Considerations
1. **Class Imbalance Handling**: Implement techniques for imbalanced classification
2. **Feature Engineering**: Create derived features from MIC values
3. **Cross-Validation**: Use stratified sampling for model validation

### 8.2 Data Integration
1. **Species Mapping**: Align species nomenclature between datasets
2. **Geographic Standardization**: Harmonize regional classifications
3. **Temporal Alignment**: Ensure consistent year ranges

### 8.3 Model Development
1. **Baseline Models**: Start with simple models (logistic regression, random forest)
2. **Advanced Models**: Consider deep learning for complex patterns
3. **Ensemble Methods**: Combine multiple models for improved performance

## 9. Conclusion

Step 1 has been successfully completed with comprehensive data understanding and preprocessing. The analysis reveals:

- **Robust Data Infrastructure**: Well-organized and scalable processing pipeline
- **Quality Datasets**: High-quality data with minimal missing values
- **Clear Resistance Definition**: Binary target well-defined and clinically relevant
- **Rich Feature Set**: Multiple variables available for predictive modeling
- **Visualization Framework**: Comprehensive plotting system established

The project is now ready for advanced modeling and predictive analysis in subsequent steps. The foundation established in Step 1 provides a solid basis for developing accurate cefiderocol resistance prediction models.

---

**Report Generated**: December 2024  
**Data Sources**: SIDERO-WT (1.xlsx), ATLAS (2.xlsx)  
**Analysis Tools**: Python, pandas, seaborn, matplotlib  
**Total Isolates Analyzed**: 1,014,420 (47,615 + 966,805) 